Traynor Capital Management, Inc. Novartis Ag Transaction History

Traynor Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 14, 2021	SELL	$78.07 - $94.43 $1.13 Million - $1.36 Million	-14,449 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$82.14 - $91.0 $46,409 - $51,415	-565 Reduced 3.76%	14,449 $1.22 Million
Q2 2020 Aug 10, 2020	BUY	$80.93 - $91.1 $941,296 - $1.06 Million	11,631 Added 343.81%	15,014 $1.31 Million
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $85,581 - $119,901	1,211 Added 55.76%	3,383 $278,000
Q4 2019 Jan 24, 2020	BUY	$84.35 - $95.37 $183,208 - $207,143	2,172 New	2,172 $205,000
Q2 2019 Jul 26, 2019	SELL	$75.4 - $92.8 $181,337 - $223,184	-2,405 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$75.32 - $86.15 $181,144 - $207,190	2,405 New	2,405 $231,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.